Related Experiment Videos
A CAV3 microdeletion differentially affects skeletal muscle and myocardium
R Cagliani1, N Bresolin, A Prelle
1I.R.C.C.S.E. Medea, Bosisio Parini, Italy. rcagliani@bp.lnf.it
Neurology
|December 10, 2003
Summary
A CAV3 gene mutation causes muscle disease with varied symptoms, including limb-girdle muscular dystrophy and hyperCKemia. The mutation leads to caveolin-3 deficiency in skeletal muscle but is less severe in the heart.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Caveolin-3 (CAV3) is a muscle protein crucial for caveolae formation.
- Mutations in CAV3 cause limb-girdle muscular dystrophy type 1C (LGMD-1C), rippling muscle disease (RMD), hyperCKemia, and distal myopathy.
Purpose of the Study:
- To investigate a multigenerational Italian family with an autosomal dominant myopathic disorder.
- To analyze caveolin-3 expression and its impact on other muscle proteins in affected individuals.
Main Methods:
- Clinical evaluation of 15 family members.
- Immunohistochemistry and Western blot analysis of skeletal muscle proteins.
- Electron microscopy of muscle and heart biopsies.
Main Results:
- A heterozygous 3-bp microdeletion (Phe97del) in CAV3 was identified in affected individuals.
- Skeletal muscle showed severe caveolin-3 deficiency and disorganized caveolae.
- Myocardium exhibited preserved caveolin-3 localization and function, despite reduced expression.
Conclusions:
- CAV3 Phe97 microdeletion results in intrafamilial phenotypic heterogeneity.
- Skeletal muscle and cardiac molecular networks interacting with caveolin-3 may differ.